This Interventional Neurology Devices and Equipment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The interventional neurology devices and equipment market size has grown strongly in recent years. It will grow from $2.33 billion in 2024 to $2.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, patient demand for minimally invasive procedures, clinical guidelines and research.
The interventional neurology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, robot-assisted interventions. Major trends in the forecast period include advanced imaging technologies, artificial intelligence (ai) in interventional cardiology, complex lesion treatments, next-generation drug-eluting stents (des).
The Interventional neurology devices market is experiencing growth driven by the increasing number of patients with neurological disorders. Neurological disorders, such as Alzheimer's disease, cerebrovascular diseases including stroke, migraines, and other headache disorders, are on the rise. Several factors contribute to the surge in neurological disorders, including the rapid increase in the geriatric population, elevated stress levels among young individuals, and head injuries resulting from accidents. For instance, the Brain Aneurysm Foundation estimates that approximately 6 million people in the United States suffer from unruptured brain aneurysms. Additionally, according to the World Health Organization, over 50 million individuals have epilepsy, and more than 47 million are affected by dementia. Consequently, the substantial increase in the incidence of neurological disorders is poised to drive market growth during the forecast period.
The demand for minimally invasive treatments is expected to be a key driver of the interventional neurology devices and equipment market in the future. Minimally invasive treatments involve medical interventions designed to achieve therapeutic or diagnostic outcomes with minimal disruption to the body's tissues and structures. In the treatment of neurological disorders, minimally invasive procedures are gaining popularity, utilizing interventional neurology devices to offer safer, more effective, and less disruptive options for patients. For example, in January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicated that there were approximately 1,875,000 surgical procedures performed using the Vinci Surgical System. This marked a significant 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the growing demand for minimally invasive treatments is a driving force behind the expansion of the interventional neurology devices and equipment market.
The latest technological development by Stryker Inc., the Neuroform Atlas Stent System, is anticipated to deliver significant results in the treatment of brain aneurysms with embolic coils. The introduction of such technologies is expected to drive the interventional neurological device market in the future. The Atlas stent system offers robust support during coiling procedures, designed to provide the necessary coil support and wall apposition for effective stent-assisted coiling. Neuroform Atlas features enhanced stent conformability, a low-profile delivery system, and high deployment accuracy even in distal anatomy, making it the preferred choice among neurosurgeons and steering the market.
Prominent companies operating in the interventional neurology devices and equipment market are actively developing innovative products like SenTiva DUO to offer a new treatment option for patients with drug-resistant epilepsy who were previously ineligible for the latest VNS therapy. SenTiva DUO is an implantable pulse generator (IPG) with a dual-pin header designed to provide vagus nerve stimulation (VNS) therapy for drug-resistant epilepsy treatment. For instance, in February 2023, LivaNova Plc., a UK-based medical device company, introduced SenTiva DUO, offering a new treatment option for patients with drug-resistant epilepsy who were previously unable to receive the latest VNS therapy. It presents several advantages over the original SenTiva, including a smaller size, longer battery life, and compatibility with dual-pin leads.
Major companies operating in the interventional neurology devices and equipment market include Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra Inc., COVIDien, Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates, Bayer AG, MicroPort Scientific Corporation, Boston Scientific Corporation, Johnson & Johnson, Medikit Co. Ltd., Acandis GmbH, Biosensors International Ltd., Integra LifeSciences Holdings Corporation, Magstim C-Ltd., UreSil LLC, Cook Group Incorporated, Siemens Healthineers, B. Braun Melsungen AG, Integer Holdings Corporation, Nihon Kohden Corporation, LivaNova, Teleflex Incorporated, Balt Extrusion SAS, Rapid Medical Ltd., phenox GmbH, Spiegelberg GmbH & Co. KG.
Interventional neurology devices and equipment play a critical role in the treatment of neurovascular diseases, including conditions such as aneurysms, arteriovenous malformations, cavernous malformations, and strokes.
The primary categories of interventional neurology devices and equipment include aneurysm coiling and embolization devices, cerebrospinal fluid management devices, neuro thrombectomy devices, and various support devices. Neuro thrombectomy devices are utilized for the mechanical removal of thrombi from intracranial arteries via angiographic procedures. Aneurysm coiling and embolization devices consist of embolic coils, flow diversion devices, and liquid embolic devices. The angioplasty device category includes carotid artery stents and embolic protection systems. Support devices encompass micro guidewires and microcatheters, while neurothrombectomy devices are further divided into clot retrieval devices, suction and aspiration devices, and snares. These devices find application in a range of healthcare settings, including hospitals, neurology clinics, ambulatory care centers, and others.
The interventional neurology devices and equipment market research report is one of a series of new reports that provides interventional neurology devices and equipment market statistics, including interventional neurology devices and equipment industry global market size, regional shares, competitors with a interventional neurology devices and equipment market share, detailed interventional neurology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neurology devices and equipment industry. This interventional neurology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the global interventional neurology devices and equipment market in 2024. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in the interventional neurology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the interventional neurology devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The interventional neurology devices and equipment market consists of sales of instruments such as carotid artery stents, embolic protection systems, micro guide wires, and micro catheters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The interventional neurology devices and equipment market size has grown strongly in recent years. It will grow from $2.33 billion in 2024 to $2.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, patient demand for minimally invasive procedures, clinical guidelines and research.
The interventional neurology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, robot-assisted interventions. Major trends in the forecast period include advanced imaging technologies, artificial intelligence (ai) in interventional cardiology, complex lesion treatments, next-generation drug-eluting stents (des).
The Interventional neurology devices market is experiencing growth driven by the increasing number of patients with neurological disorders. Neurological disorders, such as Alzheimer's disease, cerebrovascular diseases including stroke, migraines, and other headache disorders, are on the rise. Several factors contribute to the surge in neurological disorders, including the rapid increase in the geriatric population, elevated stress levels among young individuals, and head injuries resulting from accidents. For instance, the Brain Aneurysm Foundation estimates that approximately 6 million people in the United States suffer from unruptured brain aneurysms. Additionally, according to the World Health Organization, over 50 million individuals have epilepsy, and more than 47 million are affected by dementia. Consequently, the substantial increase in the incidence of neurological disorders is poised to drive market growth during the forecast period.
The demand for minimally invasive treatments is expected to be a key driver of the interventional neurology devices and equipment market in the future. Minimally invasive treatments involve medical interventions designed to achieve therapeutic or diagnostic outcomes with minimal disruption to the body's tissues and structures. In the treatment of neurological disorders, minimally invasive procedures are gaining popularity, utilizing interventional neurology devices to offer safer, more effective, and less disruptive options for patients. For example, in January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicated that there were approximately 1,875,000 surgical procedures performed using the Vinci Surgical System. This marked a significant 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the growing demand for minimally invasive treatments is a driving force behind the expansion of the interventional neurology devices and equipment market.
The latest technological development by Stryker Inc., the Neuroform Atlas Stent System, is anticipated to deliver significant results in the treatment of brain aneurysms with embolic coils. The introduction of such technologies is expected to drive the interventional neurological device market in the future. The Atlas stent system offers robust support during coiling procedures, designed to provide the necessary coil support and wall apposition for effective stent-assisted coiling. Neuroform Atlas features enhanced stent conformability, a low-profile delivery system, and high deployment accuracy even in distal anatomy, making it the preferred choice among neurosurgeons and steering the market.
Prominent companies operating in the interventional neurology devices and equipment market are actively developing innovative products like SenTiva DUO to offer a new treatment option for patients with drug-resistant epilepsy who were previously ineligible for the latest VNS therapy. SenTiva DUO is an implantable pulse generator (IPG) with a dual-pin header designed to provide vagus nerve stimulation (VNS) therapy for drug-resistant epilepsy treatment. For instance, in February 2023, LivaNova Plc., a UK-based medical device company, introduced SenTiva DUO, offering a new treatment option for patients with drug-resistant epilepsy who were previously unable to receive the latest VNS therapy. It presents several advantages over the original SenTiva, including a smaller size, longer battery life, and compatibility with dual-pin leads.
Major companies operating in the interventional neurology devices and equipment market include Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra Inc., COVIDien, Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates, Bayer AG, MicroPort Scientific Corporation, Boston Scientific Corporation, Johnson & Johnson, Medikit Co. Ltd., Acandis GmbH, Biosensors International Ltd., Integra LifeSciences Holdings Corporation, Magstim C-Ltd., UreSil LLC, Cook Group Incorporated, Siemens Healthineers, B. Braun Melsungen AG, Integer Holdings Corporation, Nihon Kohden Corporation, LivaNova, Teleflex Incorporated, Balt Extrusion SAS, Rapid Medical Ltd., phenox GmbH, Spiegelberg GmbH & Co. KG.
Interventional neurology devices and equipment play a critical role in the treatment of neurovascular diseases, including conditions such as aneurysms, arteriovenous malformations, cavernous malformations, and strokes.
The primary categories of interventional neurology devices and equipment include aneurysm coiling and embolization devices, cerebrospinal fluid management devices, neuro thrombectomy devices, and various support devices. Neuro thrombectomy devices are utilized for the mechanical removal of thrombi from intracranial arteries via angiographic procedures. Aneurysm coiling and embolization devices consist of embolic coils, flow diversion devices, and liquid embolic devices. The angioplasty device category includes carotid artery stents and embolic protection systems. Support devices encompass micro guidewires and microcatheters, while neurothrombectomy devices are further divided into clot retrieval devices, suction and aspiration devices, and snares. These devices find application in a range of healthcare settings, including hospitals, neurology clinics, ambulatory care centers, and others.
The interventional neurology devices and equipment market research report is one of a series of new reports that provides interventional neurology devices and equipment market statistics, including interventional neurology devices and equipment industry global market size, regional shares, competitors with a interventional neurology devices and equipment market share, detailed interventional neurology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neurology devices and equipment industry. This interventional neurology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the global interventional neurology devices and equipment market in 2024. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in the interventional neurology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the interventional neurology devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The interventional neurology devices and equipment market consists of sales of instruments such as carotid artery stents, embolic protection systems, micro guide wires, and micro catheters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Interventional Neurology Devices and Equipment Market Characteristics3. Interventional Neurology Devices and Equipment Market Trends and Strategies4. Interventional Neurology Devices and Equipment Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market68. Global Interventional Neurology Devices and Equipment Market Competitive Benchmarking and Dashboard69. Key Mergers and Acquisitions in the Interventional Neurology Devices and Equipment Market70. Recent Developments in the Interventional Neurology Devices and Equipment Market
5. Global Interventional Neurology Devices and Equipment Growth Analysis and Strategic Analysis Framework
6. Interventional Neurology Devices and Equipment Market Segmentation
7. Interventional Neurology Devices and Equipment Market Regional and Country Analysis
8. Asia-Pacific Interventional Neurology Devices and Equipment Market
9. China Interventional Neurology Devices and Equipment Market
10. India Interventional Neurology Devices and Equipment Market
11. Japan Interventional Neurology Devices and Equipment Market
12. Australia Interventional Neurology Devices and Equipment Market
13. Indonesia Interventional Neurology Devices and Equipment Market
14. South Korea Interventional Neurology Devices and Equipment Market
15. Bangladesh Interventional Neurology Devices and Equipment Market
16. Thailand Interventional Neurology Devices and Equipment Market
17. Vietnam Interventional Neurology Devices and Equipment Market
18. Malaysia Interventional Neurology Devices and Equipment Market
19. Singapore Interventional Neurology Devices and Equipment Market
20. Philippines Interventional Neurology Devices and Equipment Market
21. Hong Kong Interventional Neurology Devices and Equipment Market
22. New Zealand Interventional Neurology Devices and Equipment Market
23. Western Europe Interventional Neurology Devices and Equipment Market
24. UK Interventional Neurology Devices and Equipment Market
25. Germany Interventional Neurology Devices and Equipment Market
26. France Interventional Neurology Devices and Equipment Market
27. Italy Interventional Neurology Devices and Equipment Market
28. Spain Interventional Neurology Devices and Equipment Market
29. Spain Interventional Neurology Devices and Equipment Market
30. Austria Interventional Neurology Devices and Equipment Market
31. Belgium Interventional Neurology Devices and Equipment Market
32. Denmark Interventional Neurology Devices and Equipment Market
33. Finland Interventional Neurology Devices and Equipment Market
34. Ireland Interventional Neurology Devices and Equipment Market
35. Netherlands Interventional Neurology Devices and Equipment Market
36. Norway Interventional Neurology Devices and Equipment Market
37. Portugal Interventional Neurology Devices and Equipment Market
38. Sweden Interventional Neurology Devices and Equipment Market
39. Switzerland Interventional Neurology Devices and Equipment Market
40. Eastern Europe Interventional Neurology Devices and Equipment Market
41. Russia Interventional Neurology Devices and Equipment Market
42. Czech Republic Interventional Neurology Devices and Equipment Market
43. Poland Interventional Neurology Devices and Equipment Market
44. Romania Interventional Neurology Devices and Equipment Market
45. Ukraine Interventional Neurology Devices and Equipment Market
46. North America Interventional Neurology Devices and Equipment Market
47. USA Interventional Neurology Devices and Equipment Market
48. Canada Interventional Neurology Devices and Equipment Market
50. South America Interventional Neurology Devices and Equipment Market
51. Brazil Interventional Neurology Devices and Equipment Market
52. Chile Interventional Neurology Devices and Equipment Market
53. Argentina Interventional Neurology Devices and Equipment Market
54. Colombia Interventional Neurology Devices and Equipment Market
55. Peru Interventional Neurology Devices and Equipment Market
56. Middle East Interventional Neurology Devices and Equipment Market
57. Saudi Arabia Interventional Neurology Devices and Equipment Market
58. Israel Interventional Neurology Devices and Equipment Market
59. Iran Interventional Neurology Devices and Equipment Market
60. Turkey Interventional Neurology Devices and Equipment Market
61. United Arab Emirates Interventional Neurology Devices and Equipment Market
62. Africa Interventional Neurology Devices and Equipment Market
63. Egypt Interventional Neurology Devices and Equipment Market
64. Nigeria Interventional Neurology Devices and Equipment Market
65. South Africa Interventional Neurology Devices and Equipment Market
66. Interventional Neurology Devices and Equipment Market Competitive Landscape and Company Profiles
67. Interventional Neurology Devices and Equipment Market Other Major and Innovative Companies
71. Interventional Neurology Devices and Equipment Market High Potential Countries, Segments and Strategies
72. Appendix
Executive Summary
Interventional Neurology Devices and Equipment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on interventional neurology devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for interventional neurology devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional neurology devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Aneurysm Coiling and Embolization Devices; Cerebrospinal Fluid Management Devices; Neurothrombectomy Devices; Support Devices2) Aneurysm Coiling and Embolization Devices by Type: Embolic coils; Flow diversion devices; Liquid embolic devices
3) Angioplasty Devices by Type: Carotid artery stents; Embolic protection systems
4) Support Devices by Type; Micro guide wires; Micro catheters
5) Neurothrombectomy Devices by Type: CLOT retrieval devices; Suction and aspiration devices; Snare
6) By End-User: Hospitals; Neurology clinics; Ambulatory care centers and others
Subsegments:
1) By Aneurysm Coiling and Embolization Devices: Flow Diverters; Embolic Coils; Liquid Embolics2) By Cerebrospinal Fluid (CSF) Management Devices: CSF Shunts; CSF Drainage Systems
3) By Neurothrombectomy Devices: Clot Retrievers; Aspiration Devices; Snares
4) By Support Devices: Microcatheters; Guidewires
Key Companies Mentioned: Medtronic plc; Stryker Corporation; Terumo Corporation; Penumbra Inc.; COVIDien
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Interventional Neurology Devices and Equipment market report include:- Medtronic plc
- Stryker Corporation
- Terumo Corporation
- Penumbra Inc.
- COVIDien
- Abbott Laboratories
- Merit Medical Systems Inc.
- W. L. Gore & Associates
- Bayer AG
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Johnson & Johnson
- Medikit Co. Ltd.
- Acandis GmbH
- Biosensors International Ltd.
- Integra LifeSciences Holdings Corporation
- Magstim C-Ltd.
- UreSil LLC
- Cook Group Incorporated
- Siemens Healthineers
- B. Braun Melsungen AG
- Integer Holdings Corporation
- Nihon Kohden Corporation
- LivaNova
- Teleflex Incorporated
- Balt Extrusion SAS
- Rapid Medical Ltd.
- phenox GmbH
- Spiegelberg GmbH & Co. KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 2.54 Billion |
| Forecasted Market Value ( USD | $ 3.61 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
